Presentation THT 2022 From Access to Anchors: The AccuCinch Ventricular Restoration System Presenter: Mohamed Latib February 01, 2022
Presentation THT 2022 Reverse Remodeling in Heart Failure Presenter: Daniel Burkhoff February 01, 2022
News Daily News In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report Michael O'Riordan January 27, 2022
News Daily News Journal of Cardiac Failure Launches Rapid Publication Platform to Spark Discourse Todd Neale January 21, 2022
News Daily News Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF L.A. McKeown December 07, 2021
Presentation Controversies and Advances 2021 In Defense of Digoxin Presenter: John Mandrola December 03, 2021
Presentation Controversies and Advances 2021 SGLT2 Inhibitors and Heart Failure Presenter: Michelle M. Kittleson December 03, 2021
Presentation Controversies and Advances 2021 Role of Digoxin in Heart Failure and Atrial Fibrillation Presenter: Michelle M. Kittleson December 03, 2021
News Conference News AHA 2021 Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF Michael O'Riordan November 19, 2021
News Conference News AHA 2021 Empagliflozin Retains Benefits in ‘True’ HFpEF Patients Todd Neale November 17, 2021
News Conference News AHA 2021 Canagliflozin Improves Quality of Life in HF Patients Michael O'Riordan November 16, 2021
News Conference News AHA 2021 Empagliflozin Safe in Acute HF, Improves ‘Clinical Benefit’ Over Time: EMPULSE Shelley Wood November 14, 2021
News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
News Conference News TCT 2021 GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF Michael O'Riordan November 06, 2021
News Daily News As Amyloidosis Field Explodes, Physicians Need to Spot and Treat Todd Neale October 20, 2021